Age‐related differences in patients with nonpalpable breast carcinomas

BACKGROUND The survival benefit of screening mammography may be influenced by the age of the screened population. The current series examines the influence of age on the clinical, histopathologic, and prognostic features of nonpalpable breast carcinoma. METHODS Needle localization and biopsy of susp...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Cancer 1996-10, Vol.78 (7), p.1432-1437
Hauptverfasser: Wazer, David E., Gage, Irene, Homer, Marc J., Krosnick, Steven H., Schmid, Christopher
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 1437
container_issue 7
container_start_page 1432
container_title Cancer
container_volume 78
creator Wazer, David E.
Gage, Irene
Homer, Marc J.
Krosnick, Steven H.
Schmid, Christopher
description BACKGROUND The survival benefit of screening mammography may be influenced by the age of the screened population. The current series examines the influence of age on the clinical, histopathologic, and prognostic features of nonpalpable breast carcinoma. METHODS Needle localization and biopsy of suspicious mammographic lesions identified 173 breast carcinomas that were occult by physical examination. The mammographic appearance, the tumor histology and size, as well as axillary lymph node and estrogen receptor status of these carcinomas were reviewed. RESULTS Mammographic findings of a mass or density (without calcifications) were most common (46%) and the majority of tumors were invasive ductal carcinoma (70%). The median age of the patients was 59 years. Tumor histology and mammographic findings varied by age: women with ductal carcinoma in situ (DCIS) had a median age of 50 years, whereas patients with invasive ductal carcinoma without associated intraductal tumor had a median age of 65 years. Both younger age (P = 0.001) and microcalcifications (P = 0.0001) were strongly correlated with DCIS. The mean greatest tumor dimension was 1.34 cm. Axillary metastases were found in 21%, 15%, and 50% of invasive tumors with sizes of 10 fmol/mg in 47% and 84% of women aged 50 years, respectively. CONCLUSIONS Mammographically detected lesions in younger women are typified by a higher incidence of DCIS or tumors with an intraductal component. Nonpalpable invasive carcinomas in women ≤50 years and > 50 years appear to be biologically similar by virtue of axillary lymph node status, although estrogen receptor positive tumors are more common in older patients. These age‐related differences may partially account for age‐related variations in the survival impact of mammographic screening programs. Cancer 1996;78:1432‐7.
doi_str_mv 10.1002/(SICI)1097-0142(19961001)78:7<1432::AID-CNCR9>3.0.CO;2-M
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_78397648</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>78397648</sourcerecordid><originalsourceid>FETCH-LOGICAL-c3939-5c916364d813551bb463018a2b1e80b756bec26da82fc1e9cab26997f61c9b8d3</originalsourceid><addsrcrecordid>eNqFkM1u1DAUhS0EKtPCIyBlgVC7yOCfxLEHhBiFn47UMhI_Ulld2c4NGGWSYGdUdddH4Bl5EhJmmA1IrKzrc-7RuR8hLxmdM0r509MPq3J1xqguUsoyfsq0lqPAzgq1KJ6zTPDFYrl6lZbvyvf6hZjTebl-xtPLO2R2WLpLZpRSleaZuLpPjmP8No4Fz8UROVJK6DxTM3K-_II_b38EbMyAVVL5usaArcOY-DbpzeCxHWJy7YevSdu1vWl6YxtMbEATh8SZ4HzbbUx8QO7Vpon4cP-ekE9vXn8sz9OL9dtVubxIndBCp7nTTAqZVYqJPGfWZlJQpgy3DBW1RS4tOi4ro3jtGGpnLJdaF7VkTltViRPyZJfbh-77FuMAGx8dNo1psdtGKMbLCpmp0Xi1M7rQxRiwhj74jQk3wChMkAEmyDDxgokX_IE8ZkABE2SAETL8hgwCKJRr4HA5Rj_ad9jaDVaH4D3VUX-81010pqmDaZ2PB5vgQmo52T7vbNe-wZu_6v2_3b_K7T7EL7UYpfY</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>78397648</pqid></control><display><type>article</type><title>Age‐related differences in patients with nonpalpable breast carcinomas</title><source>MEDLINE</source><source>Wiley Free Content</source><source>Wiley Online Library All Journals</source><source>Alma/SFX Local Collection</source><creator>Wazer, David E. ; Gage, Irene ; Homer, Marc J. ; Krosnick, Steven H. ; Schmid, Christopher</creator><creatorcontrib>Wazer, David E. ; Gage, Irene ; Homer, Marc J. ; Krosnick, Steven H. ; Schmid, Christopher</creatorcontrib><description>BACKGROUND The survival benefit of screening mammography may be influenced by the age of the screened population. The current series examines the influence of age on the clinical, histopathologic, and prognostic features of nonpalpable breast carcinoma. METHODS Needle localization and biopsy of suspicious mammographic lesions identified 173 breast carcinomas that were occult by physical examination. The mammographic appearance, the tumor histology and size, as well as axillary lymph node and estrogen receptor status of these carcinomas were reviewed. RESULTS Mammographic findings of a mass or density (without calcifications) were most common (46%) and the majority of tumors were invasive ductal carcinoma (70%). The median age of the patients was 59 years. Tumor histology and mammographic findings varied by age: women with ductal carcinoma in situ (DCIS) had a median age of 50 years, whereas patients with invasive ductal carcinoma without associated intraductal tumor had a median age of 65 years. Both younger age (P = 0.001) and microcalcifications (P = 0.0001) were strongly correlated with DCIS. The mean greatest tumor dimension was 1.34 cm. Axillary metastases were found in 21%, 15%, and 50% of invasive tumors with sizes of &lt;1 cm, &lt;2 cm, and &gt; 2 cm, respectively, and were uninfluenced by age. Estrogen receptor analysis of invasive tumors was &gt; 10 fmol/mg in 47% and 84% of women aged &lt;50 years and &gt; 50 years, respectively. CONCLUSIONS Mammographically detected lesions in younger women are typified by a higher incidence of DCIS or tumors with an intraductal component. Nonpalpable invasive carcinomas in women ≤50 years and &gt; 50 years appear to be biologically similar by virtue of axillary lymph node status, although estrogen receptor positive tumors are more common in older patients. These age‐related differences may partially account for age‐related variations in the survival impact of mammographic screening programs. Cancer 1996;78:1432‐7.</description><identifier>ISSN: 0008-543X</identifier><identifier>EISSN: 1097-0142</identifier><identifier>DOI: 10.1002/(SICI)1097-0142(19961001)78:7&lt;1432::AID-CNCR9&gt;3.0.CO;2-M</identifier><identifier>PMID: 8839548</identifier><identifier>CODEN: CANCAR</identifier><language>eng</language><publisher>New York: Wiley Subscription Services, Inc., A Wiley Company</publisher><subject>Adult ; Age Factors ; Aged ; Aged, 80 and over ; Biological and medical sciences ; Biopsy, Needle ; breast neoplasms ; Breast Neoplasms - diagnostic imaging ; Breast Neoplasms - mortality ; Breast Neoplasms - pathology ; Carcinoma, Ductal, Breast - diagnostic imaging ; Carcinoma, Ductal, Breast - mortality ; Carcinoma, Ductal, Breast - pathology ; ductal carcinoma ; Female ; Gynecology. Andrology. Obstetrics ; Humans ; intraductal carcinoma ; Mammary gland diseases ; Mammography ; Medical sciences ; Middle Aged ; nonpalpable breast carcinoma ; Prognosis ; Receptors, Estrogen ; Tumors</subject><ispartof>Cancer, 1996-10, Vol.78 (7), p.1432-1437</ispartof><rights>Copyright © 1996 American Cancer Society</rights><rights>1996 INIST-CNRS</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c3939-5c916364d813551bb463018a2b1e80b756bec26da82fc1e9cab26997f61c9b8d3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1002%2F%28SICI%291097-0142%2819961001%2978%3A7%3C1432%3A%3AAID-CNCR9%3E3.0.CO%3B2-M$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1002%2F%28SICI%291097-0142%2819961001%2978%3A7%3C1432%3A%3AAID-CNCR9%3E3.0.CO%3B2-M$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>314,780,784,1417,1433,27924,27925,45574,45575,46409,46833</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=3236968$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/8839548$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Wazer, David E.</creatorcontrib><creatorcontrib>Gage, Irene</creatorcontrib><creatorcontrib>Homer, Marc J.</creatorcontrib><creatorcontrib>Krosnick, Steven H.</creatorcontrib><creatorcontrib>Schmid, Christopher</creatorcontrib><title>Age‐related differences in patients with nonpalpable breast carcinomas</title><title>Cancer</title><addtitle>Cancer</addtitle><description>BACKGROUND The survival benefit of screening mammography may be influenced by the age of the screened population. The current series examines the influence of age on the clinical, histopathologic, and prognostic features of nonpalpable breast carcinoma. METHODS Needle localization and biopsy of suspicious mammographic lesions identified 173 breast carcinomas that were occult by physical examination. The mammographic appearance, the tumor histology and size, as well as axillary lymph node and estrogen receptor status of these carcinomas were reviewed. RESULTS Mammographic findings of a mass or density (without calcifications) were most common (46%) and the majority of tumors were invasive ductal carcinoma (70%). The median age of the patients was 59 years. Tumor histology and mammographic findings varied by age: women with ductal carcinoma in situ (DCIS) had a median age of 50 years, whereas patients with invasive ductal carcinoma without associated intraductal tumor had a median age of 65 years. Both younger age (P = 0.001) and microcalcifications (P = 0.0001) were strongly correlated with DCIS. The mean greatest tumor dimension was 1.34 cm. Axillary metastases were found in 21%, 15%, and 50% of invasive tumors with sizes of &lt;1 cm, &lt;2 cm, and &gt; 2 cm, respectively, and were uninfluenced by age. Estrogen receptor analysis of invasive tumors was &gt; 10 fmol/mg in 47% and 84% of women aged &lt;50 years and &gt; 50 years, respectively. CONCLUSIONS Mammographically detected lesions in younger women are typified by a higher incidence of DCIS or tumors with an intraductal component. Nonpalpable invasive carcinomas in women ≤50 years and &gt; 50 years appear to be biologically similar by virtue of axillary lymph node status, although estrogen receptor positive tumors are more common in older patients. These age‐related differences may partially account for age‐related variations in the survival impact of mammographic screening programs. Cancer 1996;78:1432‐7.</description><subject>Adult</subject><subject>Age Factors</subject><subject>Aged</subject><subject>Aged, 80 and over</subject><subject>Biological and medical sciences</subject><subject>Biopsy, Needle</subject><subject>breast neoplasms</subject><subject>Breast Neoplasms - diagnostic imaging</subject><subject>Breast Neoplasms - mortality</subject><subject>Breast Neoplasms - pathology</subject><subject>Carcinoma, Ductal, Breast - diagnostic imaging</subject><subject>Carcinoma, Ductal, Breast - mortality</subject><subject>Carcinoma, Ductal, Breast - pathology</subject><subject>ductal carcinoma</subject><subject>Female</subject><subject>Gynecology. Andrology. Obstetrics</subject><subject>Humans</subject><subject>intraductal carcinoma</subject><subject>Mammary gland diseases</subject><subject>Mammography</subject><subject>Medical sciences</subject><subject>Middle Aged</subject><subject>nonpalpable breast carcinoma</subject><subject>Prognosis</subject><subject>Receptors, Estrogen</subject><subject>Tumors</subject><issn>0008-543X</issn><issn>1097-0142</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1996</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFkM1u1DAUhS0EKtPCIyBlgVC7yOCfxLEHhBiFn47UMhI_Ulld2c4NGGWSYGdUdddH4Bl5EhJmmA1IrKzrc-7RuR8hLxmdM0r509MPq3J1xqguUsoyfsq0lqPAzgq1KJ6zTPDFYrl6lZbvyvf6hZjTebl-xtPLO2R2WLpLZpRSleaZuLpPjmP8No4Fz8UROVJK6DxTM3K-_II_b38EbMyAVVL5usaArcOY-DbpzeCxHWJy7YevSdu1vWl6YxtMbEATh8SZ4HzbbUx8QO7Vpon4cP-ekE9vXn8sz9OL9dtVubxIndBCp7nTTAqZVYqJPGfWZlJQpgy3DBW1RS4tOi4ro3jtGGpnLJdaF7VkTltViRPyZJfbh-77FuMAGx8dNo1psdtGKMbLCpmp0Xi1M7rQxRiwhj74jQk3wChMkAEmyDDxgokX_IE8ZkABE2SAETL8hgwCKJRr4HA5Rj_ad9jaDVaH4D3VUX-81010pqmDaZ2PB5vgQmo52T7vbNe-wZu_6v2_3b_K7T7EL7UYpfY</recordid><startdate>19961001</startdate><enddate>19961001</enddate><creator>Wazer, David E.</creator><creator>Gage, Irene</creator><creator>Homer, Marc J.</creator><creator>Krosnick, Steven H.</creator><creator>Schmid, Christopher</creator><general>Wiley Subscription Services, Inc., A Wiley Company</general><general>Wiley-Liss</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>19961001</creationdate><title>Age‐related differences in patients with nonpalpable breast carcinomas</title><author>Wazer, David E. ; Gage, Irene ; Homer, Marc J. ; Krosnick, Steven H. ; Schmid, Christopher</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c3939-5c916364d813551bb463018a2b1e80b756bec26da82fc1e9cab26997f61c9b8d3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1996</creationdate><topic>Adult</topic><topic>Age Factors</topic><topic>Aged</topic><topic>Aged, 80 and over</topic><topic>Biological and medical sciences</topic><topic>Biopsy, Needle</topic><topic>breast neoplasms</topic><topic>Breast Neoplasms - diagnostic imaging</topic><topic>Breast Neoplasms - mortality</topic><topic>Breast Neoplasms - pathology</topic><topic>Carcinoma, Ductal, Breast - diagnostic imaging</topic><topic>Carcinoma, Ductal, Breast - mortality</topic><topic>Carcinoma, Ductal, Breast - pathology</topic><topic>ductal carcinoma</topic><topic>Female</topic><topic>Gynecology. Andrology. Obstetrics</topic><topic>Humans</topic><topic>intraductal carcinoma</topic><topic>Mammary gland diseases</topic><topic>Mammography</topic><topic>Medical sciences</topic><topic>Middle Aged</topic><topic>nonpalpable breast carcinoma</topic><topic>Prognosis</topic><topic>Receptors, Estrogen</topic><topic>Tumors</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Wazer, David E.</creatorcontrib><creatorcontrib>Gage, Irene</creatorcontrib><creatorcontrib>Homer, Marc J.</creatorcontrib><creatorcontrib>Krosnick, Steven H.</creatorcontrib><creatorcontrib>Schmid, Christopher</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Cancer</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Wazer, David E.</au><au>Gage, Irene</au><au>Homer, Marc J.</au><au>Krosnick, Steven H.</au><au>Schmid, Christopher</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Age‐related differences in patients with nonpalpable breast carcinomas</atitle><jtitle>Cancer</jtitle><addtitle>Cancer</addtitle><date>1996-10-01</date><risdate>1996</risdate><volume>78</volume><issue>7</issue><spage>1432</spage><epage>1437</epage><pages>1432-1437</pages><issn>0008-543X</issn><eissn>1097-0142</eissn><coden>CANCAR</coden><abstract>BACKGROUND The survival benefit of screening mammography may be influenced by the age of the screened population. The current series examines the influence of age on the clinical, histopathologic, and prognostic features of nonpalpable breast carcinoma. METHODS Needle localization and biopsy of suspicious mammographic lesions identified 173 breast carcinomas that were occult by physical examination. The mammographic appearance, the tumor histology and size, as well as axillary lymph node and estrogen receptor status of these carcinomas were reviewed. RESULTS Mammographic findings of a mass or density (without calcifications) were most common (46%) and the majority of tumors were invasive ductal carcinoma (70%). The median age of the patients was 59 years. Tumor histology and mammographic findings varied by age: women with ductal carcinoma in situ (DCIS) had a median age of 50 years, whereas patients with invasive ductal carcinoma without associated intraductal tumor had a median age of 65 years. Both younger age (P = 0.001) and microcalcifications (P = 0.0001) were strongly correlated with DCIS. The mean greatest tumor dimension was 1.34 cm. Axillary metastases were found in 21%, 15%, and 50% of invasive tumors with sizes of &lt;1 cm, &lt;2 cm, and &gt; 2 cm, respectively, and were uninfluenced by age. Estrogen receptor analysis of invasive tumors was &gt; 10 fmol/mg in 47% and 84% of women aged &lt;50 years and &gt; 50 years, respectively. CONCLUSIONS Mammographically detected lesions in younger women are typified by a higher incidence of DCIS or tumors with an intraductal component. Nonpalpable invasive carcinomas in women ≤50 years and &gt; 50 years appear to be biologically similar by virtue of axillary lymph node status, although estrogen receptor positive tumors are more common in older patients. These age‐related differences may partially account for age‐related variations in the survival impact of mammographic screening programs. Cancer 1996;78:1432‐7.</abstract><cop>New York</cop><pub>Wiley Subscription Services, Inc., A Wiley Company</pub><pmid>8839548</pmid><doi>10.1002/(SICI)1097-0142(19961001)78:7&lt;1432::AID-CNCR9&gt;3.0.CO;2-M</doi><tpages>6</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0008-543X
ispartof Cancer, 1996-10, Vol.78 (7), p.1432-1437
issn 0008-543X
1097-0142
language eng
recordid cdi_proquest_miscellaneous_78397648
source MEDLINE; Wiley Free Content; Wiley Online Library All Journals; Alma/SFX Local Collection
subjects Adult
Age Factors
Aged
Aged, 80 and over
Biological and medical sciences
Biopsy, Needle
breast neoplasms
Breast Neoplasms - diagnostic imaging
Breast Neoplasms - mortality
Breast Neoplasms - pathology
Carcinoma, Ductal, Breast - diagnostic imaging
Carcinoma, Ductal, Breast - mortality
Carcinoma, Ductal, Breast - pathology
ductal carcinoma
Female
Gynecology. Andrology. Obstetrics
Humans
intraductal carcinoma
Mammary gland diseases
Mammography
Medical sciences
Middle Aged
nonpalpable breast carcinoma
Prognosis
Receptors, Estrogen
Tumors
title Age‐related differences in patients with nonpalpable breast carcinomas
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-08T05%3A25%3A42IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Age%E2%80%90related%20differences%20in%20patients%20with%20nonpalpable%20breast%20carcinomas&rft.jtitle=Cancer&rft.au=Wazer,%20David%20E.&rft.date=1996-10-01&rft.volume=78&rft.issue=7&rft.spage=1432&rft.epage=1437&rft.pages=1432-1437&rft.issn=0008-543X&rft.eissn=1097-0142&rft.coden=CANCAR&rft_id=info:doi/10.1002/(SICI)1097-0142(19961001)78:7%3C1432::AID-CNCR9%3E3.0.CO;2-M&rft_dat=%3Cproquest_cross%3E78397648%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=78397648&rft_id=info:pmid/8839548&rfr_iscdi=true